These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 14632962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE.
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [Abstract] [Full Text] [Related]

  • 6. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR, Mulder RT, McKenzie JM, Luty SE, Cloninger CR.
    Depress Anxiety; 2004 Jan; 19(3):180-6. PubMed ID: 15129420
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Jan; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 8. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.
    Joyce PR, Mulder RT, Luty SE, McKenzie JM, Sullivan PF, Abbott RM, Stevens IF.
    Aust N Z J Psychiatry; 2002 Jun; 36(3):376-83. PubMed ID: 12060187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K, Kosier JT, Robinson RG.
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C, Ceccherininelli A, Rossi A, Maggini C.
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationships among measures of treatment outcome in depressed patients.
    Mulder RT, Joyce PR, Frampton C.
    J Affect Disord; 2003 Sep; 76(1-3):127-35. PubMed ID: 12943942
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF.
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.